Mark R. Nicolls MD
Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor at Stanford/VA Palo Alto Chief, Pulmonary, Allergy & Critical Care Medicine at Stanford Associate Dean of Research
Join to view full profile
1701 Page Mill RoadPalo Alto, CA 94304
Phone+1 650-862-7158
Fax+1 650-723-0074
Dr. Nicolls is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Nicolls is a pulmonologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and VA Palo Alto Health Care System. He received his medical degree from Stanford University School of Medicine and has been in practice 24 years. He specializes in lung transplantation medicine, pleural disease, and pulmonary vascular medicine and is experienced in transplant pulmonology, lung transplantation, critical care medicine, bronchiolitis obliterans, lymphatic disease, and general pulmonology.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
Stanford University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2007 - 2026
CO State Medical License 1997 - 2009
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Association of American Physicians 2020
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
Clinical Trials
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Publications & Presentations
PubMed
- Power and sample-size estimation in human microbiome research.Qianyi Zhou, Yingzhou Lu, Luman Wang, Wei Zhou, Haley Oba
Med. 2026-07-10 - Hypoxia Induces Adaptive Lymphangiogenesis via Cd74 and Vegfr3 to Modulate Pulmonary Hypertension.M Elizabeth Moss, Timothy Klouda, Yan Li, Yu Liu, Meng Tan
Circulation Research. 2026-07-06 - CES1 deficiency is associated with metabolic reprograming and endothelial dysfunction in pulmonary arterial hypertension.Stuti Agarwal, Anuradha Bankar, Lyong Heo, Ankita Mitra, Ananya Chakraborty
American Journal of Respiratory and Critical Care Medicine. 2026-06-01
Press Mentions
Breathing Current Bay Area Air Compares to Smoking '8 Cigarettes,' Health Expert SaysSeptember 15th, 2020
Inflammation Triggers Silent Mutation to Cause Deadly Lung DiseaseAugust 29th, 2019
Anti-Inflammatory Drug Effective for Treating Lymphedema SymptomsOctober 18th, 2018
Grant Support
- BMPR2, Monocytes and Macrophages in Pulmonary Artery HypertensionSTANFORD UNIVERSITY2017–2028
- Vaccination responses in lung transplant recipientsSTANFORD UNIVERSITY2022–2027
- BMPR2 mutations, Neointimal Transformation and Pulmonary Arterial HypertensionVETERANS ADMIN PALO ALTO HEALTH CARE SYS2021–2026
- Stanford Training Program in Lung BiologySTANFORD UNIVERSITY2016–2026
- Regulatory T Cells and Pulmonary HypertensionPALO ALTO VETERANS INSTIT FOR RESEARCH2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
